
|Videos|October 24, 2015
Controlled Substance Red Flags
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some red flags related to prescriptions that can lead to administrative action from the DEA.
Advertisement
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some red flags related to prescriptions that can lead to administrative action from the DEA.
This video was recorded at the 2015 NCPA Annual Convention.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Anticoagulation in AFib: Risk Stratification, Therapy Selection, and Factor XI Inhibitors
2
Vigilance in an Age of Misinformation: Rebuilding Trust Through Evidence and Connection
3
Tarlatamab Improves Intracranial Outcomes and May Overcome Poor Prognosis in Relapsed SCLC With Brain Metastases
4
Tafasitamab Regimen Improves Survival Outcomes in Newly Diagnosed High-Risk DLBCL
5


































































































































